Chiloscyllium plagiosum isolate BGI_BamShark_2017 chromosome 29, ASM401019v2, whole genome shotgun sequence.
Chiloscyllium plagiosum (whitespotted bambooshark)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Hemiscylliidae; Chiloscyllium.
REFSEQ INFORMATION: The reference sequence is identical to\nCM012984.1.\nAssembly name: ASM401019v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the BGI on 2019/01/10. The\noriginal whole-genome shotgun project has the accession\nQPFF00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: BGI\nAssembly Method :: platanus v. 1.2.4; 3ddna v. 170123\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 280.0x\nSequencing Technology :: BGIseq-500\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chiloscyllium plagiosum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
phosphatase and actin regulator 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphatase and actin regulator 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphatase and actin regulator 1-like, transcript variant X4
phosphatase and actin regulator 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphatase and actin regulator 1-like, transcript variant X5
phosphatase and actin regulator 1-like isoform X1
phosphatase and actin regulator 1-like isoform X3
phosphatase and actin regulator 1-like isoform X4
phosphatase and actin regulator 1-like isoform X2
phosphatase and actin regulator 1-like isoform X5
TBC1 domain family, member 7, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
TBC1 domain family, member 7, transcript variant X11
TBC1 domain family, member 7, transcript variant X10
TBC1 domain family, member 7, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TBC1 domain family, member 7, transcript variant X1
TBC1 domain family, member 7, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TBC1 domain family, member 7, transcript variant X5
TBC1 domain family, member 7, transcript variant X2
TBC1 domain family, member 7, transcript variant X3
TBC1 domain family, member 7, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
TBC1 domain family, member 7, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
TBC1 domain family, member 7, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
TBC1 domain family, member 7, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ELOVL fatty acid elongase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 107 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
elongation of very long chain fatty acids protein 2 isoform X2
ELOVL fatty acid elongase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 107 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
elongation of very long chain fatty acids protein 2 isoform X1
synaptonemal complex protein 2-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
synaptonemal complex protein 2-like, transcript variant X10
synaptonemal complex protein 2-like, transcript variant X12
synaptonemal complex protein 2-like, transcript variant X2
synaptonemal complex protein 2-like, transcript variant X1
synaptonemal complex protein 2-like, transcript variant X3
synaptonemal complex protein 2-like, transcript variant X8
synaptonemal complex protein 2-like, transcript variant X6
synaptonemal complex protein 2-like, transcript variant X11
synaptonemal complex protein 2-like, transcript variant X7
synaptonemal complex protein 2-like, transcript variant X5
synaptonemal complex protein 2-like isoform X6
synaptonemal complex protein 2-like isoform X2
synaptonemal complex protein 2-like isoform X1
synaptonemal complex protein 2-like isoform X3
synaptonemal complex protein 2-like isoform X5
synaptonemal complex protein 2-like, transcript variant X4
synaptonemal complex protein 2-like isoform X4
glial cells missing transcription factor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glial cells missing transcription factor 2, transcript variant X2
glial cells missing transcription factor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chorion-specific transcription factor GCMb
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA valine (anticodon CAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
HIVEP zinc finger 1, transcript variant X2
COORDINATES: polyA evidence [ECO:0006239]
HIVEP zinc finger 1, transcript variant X3
HIVEP zinc finger 1, transcript variant X1
HIVEP zinc finger 1, transcript variant X4
HIVEP zinc finger 1, transcript variant X5
androgen-dependent TFPI-regulating protein-like, transcript variant X2
androgen-dependent TFPI-regulating protein-like, transcript variant X1
androgen-dependent TFPI-regulating protein-like, transcript variant X3
androgen-dependent TFPI-regulating protein-like isoform X1
androgen-dependent TFPI-regulating protein-like isoform X2
androgen-dependent TFPI-regulating protein-like isoform X3
transmembrane protein 170B, transcript variant X1
transmembrane protein 170B, transcript variant X2
transmembrane protein 170B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
neural precursor cell expressed, developmentally down-regulated 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
glucose-fructose oxidoreductase domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
glucose-fructose oxidoreductase domain containing 1, transcript variant X2
glucose-fructose oxidoreductase domain-containing protein 1 isoform X1
glucose-fructose oxidoreductase domain-containing protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
NAD-dependent protein deacylase sirtuin-5, mitochondrial
nucleolar protein 7, transcript variant X3
nucleolar protein 7, transcript variant X2
nucleolar protein 7, transcript variant X1
RAN binding protein 9, transcript variant X1
RAN binding protein 9, transcript variant X2
mitochondrial calcium uniporter regulator 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
mitochondrial calcium uniporter regulator 1-like, transcript variant X3
mitochondrial calcium uniporter regulator 1-like, transcript variant X1
mitochondrial calcium uniporter regulator 1-like isoform X1
mitochondrial calcium uniporter regulator 1-like isoform X2
regulator of G-protein signaling 9-binding protein-like
E3 ubiquitin-protein ligase RNF182-like, transcript variant X6
E3 ubiquitin-protein ligase RNF182-like, transcript variant X5
E3 ubiquitin-protein ligase RNF182-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
E3 ubiquitin-protein ligase RNF182-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF182-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
E3 ubiquitin-protein ligase RNF182-like, transcript variant X1
chromosome 29 C18orf21 homolog, transcript variant X1
chromosome 29 C18orf21 homolog, transcript variant X2
chromosome 29 C18orf21 homolog, transcript variant X3
CD83 antigen-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
CD83 antigen-like, transcript variant X2
CD83 antigen-like, transcript variant X1
uncharacterized protein LOC122564336 isoform X1
uncharacterized protein LOC122564336 isoform X2
uncharacterized LOC122564341, transcript variant X1
uncharacterized LOC122564341, transcript variant X3
uncharacterized LOC122564341, transcript variant X2
myosin regulatory light chain interacting protein a
dystrobrevin binding protein 1a, transcript variant X1
dystrobrevin binding protein 1a, transcript variant X2
protein Jumonji-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
protein Jumonji-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
armadillo-like helical domain-containing protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 37% coverage of the annotated genomic feature by RNAseq alignments
RHO family interacting cell polarization regulator 2, transcript variant X2
RHO family interacting cell polarization regulator 2, transcript variant X5
RHO family interacting cell polarization regulator 2, transcript variant X3
RHO family interacting cell polarization regulator 2, transcript variant X4
RHO family interacting cell polarization regulator 2, transcript variant X6
RHO family interacting cell polarization regulator 2, transcript variant X1
rho family-interacting cell polarization regulator 2 isoform X2
rho family-interacting cell polarization regulator 2 isoform X4
rho family-interacting cell polarization regulator 2 isoform X1
rho family-interacting cell polarization regulator 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122564347, transcript variant X5
uncharacterized LOC122564347, transcript variant X6
uncharacterized LOC122564347, transcript variant X3
uncharacterized LOC122564347, transcript variant X4
uncharacterized LOC122564347, transcript variant X2
uncharacterized LOC122564347, transcript variant X1
F-actin-uncapping protein LRRC16A-like, transcript variant X8
F-actin-uncapping protein LRRC16A-like, transcript variant X6
F-actin-uncapping protein LRRC16A-like, transcript variant X7
F-actin-uncapping protein LRRC16A-like, transcript variant X1
F-actin-uncapping protein LRRC16A-like, transcript variant X3
F-actin-uncapping protein LRRC16A-like, transcript variant X2
F-actin-uncapping protein LRRC16A-like, transcript variant X4
F-actin-uncapping protein LRRC16A-like, transcript variant X5
F-actin-uncapping protein LRRC16A-like isoform X1
F-actin-uncapping protein LRRC16A-like isoform X2
F-actin-uncapping protein LRRC16A-like isoform X8
F-actin-uncapping protein LRRC16A-like isoform X6
F-actin-uncapping protein LRRC16A-like isoform X7
F-actin-uncapping protein LRRC16A-like isoform X4
F-actin-uncapping protein LRRC16A-like isoform X3
F-actin-uncapping protein LRRC16A-like isoform X5
secretagogin, EF-hand calcium binding protein, transcript variant X2
secretagogin, EF-hand calcium binding protein, transcript variant X1
partitioning defective 6 homolog gamma-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
partitioning defective 6 homolog gamma-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
partitioning defective 6 homolog gamma-like isoform X1
partitioning defective 6 homolog gamma-like isoform X2
biogenesis of lysosome-related organelles complex 1 subunit 4-like
activity-dependent neuroprotector homeobox protein 2-like, transcript variant X6
activity-dependent neuroprotector homeobox protein 2-like, transcript variant X3
activity-dependent neuroprotector homeobox protein 2-like, transcript variant X2
activity-dependent neuroprotector homeobox protein 2-like, transcript variant X4
activity-dependent neuroprotector homeobox protein 2-like, transcript variant X1
activity-dependent neuroprotector homeobox protein 2-like, transcript variant X5
activity-dependent neuroprotector homeobox protein 2-like isoform X1
activity-dependent neuroprotector homeobox protein 2-like isoform X2
activity-dependent neuroprotector homeobox protein 2-like isoform X3
nuclear transport factor 2-like, transcript variant X2
nuclear transport factor 2-like isoform X2
nuclear transport factor 2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nuclear transport factor 2-like isoform X4
nuclear transport factor 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nuclear transport factor 2-like, transcript variant X3
nuclear transport factor 2-like, transcript variant X1
uncharacterized protein LOC122564279 isoform X1
nuclear transport factor 2-like isoform X3
ribosome binding factor A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ribosome binding factor A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
putative ribosome-binding factor A, mitochondrial
uncharacterized protein LOC692276 homolog
putative 2-hydroxyacid dehydrogenase SE_1879, transcript variant X1
putative 2-hydroxyacid dehydrogenase SE_1879, transcript variant X2
putative 2-hydroxyacid dehydrogenase SE_1879, transcript variant X3
putative 2-hydroxyacid dehydrogenase SE_1879
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7-like, transcript variant X1
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7-like isoform X1
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7-like isoform X2
N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase-like, transcript variant X2
N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase-like, transcript variant X3
N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase-like isoform X1
N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase-like isoform X2
N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase-like isoform X3
uncharacterized LOC122564362, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC122564362, transcript variant X3
uncharacterized LOC122564362, transcript variant X4
uncharacterized LOC122564362, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC122564362, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC122564362, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC122564362, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
stathmin domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
cyclase associated actin cytoskeleton regulatory protein 2, transcript variant X1
adenylyl cyclase-associated protein 2 isoform X1
cyclase associated actin cytoskeleton regulatory protein 2, transcript variant X2
adenylyl cyclase-associated protein 2 isoform X2
family with sequence similarity 8 member A1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
family with sequence similarity 8 member A1b, transcript variant X1
kinesin family member 13A, transcript variant X8
kinesin family member 13A, transcript variant X4
kinesin family member 13A, transcript variant X2
kinesin family member 13A, transcript variant X3
kinesin family member 13A, transcript variant X5
kinesin family member 13A, transcript variant X1
kinesin family member 13A, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
kinesin family member 13A, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
probable thiopurine S-methyltransferase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable thiopurine S-methyltransferase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
probable thiopurine S-methyltransferase isoform X1
probable thiopurine S-methyltransferase isoform X2
probable thiopurine S-methyltransferase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
probable thiopurine S-methyltransferase, transcript variant X5
probable thiopurine S-methyltransferase, transcript variant X3
probable thiopurine S-methyltransferase isoform X4
probable thiopurine S-methyltransferase isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
lysine-specific histone demethylase 1B, transcript variant X5
lysine-specific histone demethylase 1B, transcript variant X6
lysine-specific histone demethylase 1B, transcript variant X1
lysine-specific histone demethylase 1B, transcript variant X4
lysine-specific histone demethylase 1B, transcript variant X2
lysine-specific histone demethylase 1B isoform X1
lysine-specific histone demethylase 1B isoform X4
lysine-specific histone demethylase 1B isoform X5
lysine-specific histone demethylase 1B isoform X3
lysine-specific histone demethylase 1B, transcript variant X3
lysine-specific histone demethylase 1B isoform X2
DEK proto-oncogene, transcript variant X2
DEK proto-oncogene, transcript variant X1
DEK proto-oncogene, transcript variant X3
DEK proto-oncogene, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF144B-like, transcript variant X1
E3 ubiquitin-protein ligase RNF144B-like, transcript variant X2
E3 ubiquitin-protein ligase RNF144B-like
membrane bound O-acyltransferase domain containing 1, transcript variant X2
membrane bound O-acyltransferase domain containing 1, transcript variant X3
membrane bound O-acyltransferase domain containing 1, transcript variant X1
membrane bound O-acyltransferase domain containing 1, transcript variant X4
lysophospholipid acyltransferase 1 isoform X2
lysophospholipid acyltransferase 1 isoform X3
lysophospholipid acyltransferase 1 isoform X1
lysophospholipid acyltransferase 1 isoform X4
membrane bound O-acyltransferase domain containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
lysophospholipid acyltransferase 1 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
CDK5 regulatory subunit associated protein 1-like 1
threonylcarbamoyladenosine tRNA methylthiotransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
doublecortin domain-containing protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
doublecortin domain-containing protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
doublecortin domain-containing protein 2-like
magnesium transporter MRS2, transcript variant X1
magnesium transporter MRS2, transcript variant X5
magnesium transporter MRS2, transcript variant X3
magnesium transporter MRS2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
magnesium transporter MRS2, transcript variant X4
magnesium transporter MRS2, transcript variant X7
magnesium transporter MRS2 homolog, mitochondrial isoform X1
magnesium transporter MRS2 homolog, mitochondrial isoform X4
magnesium transporter MRS2 homolog, mitochondrial isoform X2
magnesium transporter MRS2 homolog, mitochondrial isoform X3
magnesium transporter MRS2, transcript variant X6
magnesium transporter MRS2 homolog, mitochondrial isoform X5
aldehyde dehydrogenase 5 family, member A1 (succinate-semialdehyde dehydrogenase)
succinate-semialdehyde dehydrogenase, mitochondrial
dyslexia-associated protein KIAA0319-like, transcript variant X4
dyslexia-associated protein KIAA0319-like, transcript variant X2
dyslexia-associated protein KIAA0319-like, transcript variant X1
dyslexia-associated protein KIAA0319-like, transcript variant X3
dyslexia-associated protein KIAA0319-like isoform X1
dyslexia-associated protein KIAA0319-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
dyslexia-associated protein KIAA0319-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
chromosome 29 C6orf62 homolog, transcript variant X2
chromosome 29 C6orf62 homolog, transcript variant X1
chromosome 29 C6orf62 homolog, transcript variant X3
uncharacterized protein C6orf62 homolog isoform X2
uncharacterized protein C6orf62 homolog isoform X1
uncharacterized protein C6orf62 homolog isoform X3
transfer RNA threonine (anticodon AGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
endonuclease/exonuclease/phosphatase family domain containing 1, transcript variant X2
endonuclease/exonuclease/phosphatase family domain containing 1, transcript variant X7
endonuclease/exonuclease/phosphatase family domain containing 1, transcript variant X3
endonuclease/exonuclease/phosphatase family domain containing 1, transcript variant X8
endonuclease/exonuclease/phosphatase family domain containing 1, transcript variant X1
endonuclease/exonuclease/phosphatase family domain containing 1, transcript variant X6
endonuclease/exonuclease/phosphatase family domain containing 1, transcript variant X4
endonuclease/exonuclease/phosphatase family domain containing 1, transcript variant X5
endonuclease/exonuclease/phosphatase family domain-containing protein 1 isoform X1
endonuclease/exonuclease/phosphatase family domain-containing protein 1 isoform X2
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 30% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein K02A2.6-like
uncharacterized protein KIAA0895-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized protein KIAA0895-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized protein KIAA0895-like isoform X1
uncharacterized protein KIAA0895-like isoform X2
engulfment and cell motility 1 (ced-12 homolog, C. elegans), transcript variant X4
engulfment and cell motility 1 (ced-12 homolog, C. elegans), transcript variant X5
engulfment and cell motility 1 (ced-12 homolog, C. elegans), transcript variant X1
engulfment and cell motility 1 (ced-12 homolog, C. elegans), transcript variant X2
engulfment and cell motility 1 (ced-12 homolog, C. elegans), transcript variant X7
engulfment and cell motility 1 (ced-12 homolog, C. elegans), transcript variant X6
engulfment and cell motility 1 (ced-12 homolog, C. elegans), transcript variant X3
engulfment and cell motility 1 (ced-12 homolog, C. elegans), transcript variant X8
engulfment and cell motility protein 1 isoform X4
engulfment and cell motility protein 1 isoform X2
engulfment and cell motility protein 1 isoform X3
engulfment and cell motility protein 1 isoform X1
engulfment and cell motility protein 1 isoform X5
RP9 pre-mRNA splicing factor, transcript variant X2
RP9 pre-mRNA splicing factor, transcript variant X1
retinitis pigmentosa 9 protein isoform X2
retinitis pigmentosa 9 protein isoform X1
uncharacterized LOC122564403, transcript variant X2
uncharacterized LOC122564403, transcript variant X1
oxysterol-binding protein-related protein 10-like, transcript variant X1
oxysterol-binding protein-related protein 10-like, transcript variant X2
oxysterol-binding protein-related protein 10-like
STT3 oligosaccharyltransferase complex catalytic subunit B
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
acidic amino acid decarboxylase GADL1-like
transforming growth factor beta receptor 2b, transcript variant X1
transforming growth factor beta receptor 2b, transcript variant X2
transforming growth factor beta receptor 2b, transcript variant X3
transforming growth factor beta receptor 2b, transcript variant X4
39S ribosomal protein L32, mitochondrial
uridine phosphorylase 1-like, transcript variant X1
uridine phosphorylase 1-like, transcript variant X4
uridine phosphorylase 1-like, transcript variant X6
uridine phosphorylase 1-like, transcript variant X3
uridine phosphorylase 1-like, transcript variant X2
uridine phosphorylase 1-like, transcript variant X5
catenin delta-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
catenin delta-2-like, transcript variant X2
catenin delta-2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
catenin delta-2-like, transcript variant X6
catenin delta-2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
catenin delta-2-like, transcript variant X5
catenin delta-2-like, transcript variant X7
ankyrin repeat domain-containing protein 33B-like, transcript variant X2
ankyrin repeat domain-containing protein 33B-like, transcript variant X1
ankyrin repeat domain-containing protein 33B-like isoform X2
ankyrin repeat domain-containing protein 33B-like isoform X1
rhophilin associated tail protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
membrane-associated ring finger (C3HC4) 6, transcript variant X1
membrane-associated ring finger (C3HC4) 6, transcript variant X2
E3 ubiquitin-protein ligase MARCH6 isoform X1
E3 ubiquitin-protein ligase MARCH6 isoform X2
genetic suppressor element 1-like, transcript variant X9
genetic suppressor element 1-like, transcript variant X1
genetic suppressor element 1-like, transcript variant X4
genetic suppressor element 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
genetic suppressor element 1-like, transcript variant X7
genetic suppressor element 1-like, transcript variant X8
genetic suppressor element 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
genetic suppressor element 1-like, transcript variant X2
genetic suppressor element 1-like, transcript variant X6
genetic suppressor element 1-like isoform X6
genetic suppressor element 1-like isoform X1
genetic suppressor element 1-like isoform X3
genetic suppressor element 1-like isoform X4
genetic suppressor element 1-like isoform X2
genetic suppressor element 1-like isoform X5
uncharacterized si:dkey-118j18.2, transcript variant X3
uncharacterized si:dkey-118j18.2, transcript variant X5
uncharacterized si:dkey-118j18.2, transcript variant X1
uncharacterized si:dkey-118j18.2, transcript variant X2
uncharacterized si:dkey-118j18.2, transcript variant X4
uncharacterized protein si:dkey-118j18.2
phosphoinositide-3-kinase, regulatory subunit 4
phosphoinositide 3-kinase regulatory subunit 4
collagen, type VI, alpha 4a, transcript variant X3
collagen, type VI, alpha 4a, transcript variant X1
collagen, type VI, alpha 4a, transcript variant X2
transfer RNA opal suppressor (anticodon UCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122564291, transcript variant X1
uncharacterized LOC122564291, transcript variant X2
SH3-domain binding protein 5b (BTK-associated)
methyltransferase 6, methylcytidine, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
tRNA N(3)-methylcytidine methyltransferase METTL6 isoform X3
methyltransferase 6, methylcytidine, transcript variant X1
methyltransferase 6, methylcytidine, transcript variant X3
methyltransferase 6, methylcytidine, transcript variant X2
methyltransferase 6, methylcytidine, transcript variant X4
tRNA N(3)-methylcytidine methyltransferase METTL6 isoform X1
tRNA N(3)-methylcytidine methyltransferase METTL6 isoform X2
maturin, neural progenitor differentiation regulator homolog (Xenopus)
E3 ubiquitin-protein ligase znrf2-like, transcript variant X2
E3 ubiquitin-protein ligase znrf2-like, transcript variant X1
E3 ubiquitin-protein ligase znrf2-like isoform X1
E3 ubiquitin-protein ligase ZNRF2-like isoform X2
nucleotide-binding oligomerization domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cystathionine gamma-lyase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
cystathionine gamma-lyase-like, transcript variant X2
cystathionine gamma-lyase-like isoform X2
cystathionine gamma-lyase-like isoform X1
nucleotide-binding oligomerization domain-containing protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nucleotide-binding oligomerization domain-containing protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nucleotide-binding oligomerization domain-containing protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nucleotide-binding oligomerization domain-containing protein 1-like isoform X2
nucleotide-binding oligomerization domain-containing protein 1-like isoform X3
nucleotide-binding oligomerization domain-containing protein 1-like isoform X1
nucleotide-binding oligomerization domain containing 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
nucleotide-binding oligomerization domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
nucleotide-binding oligomerization domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
nucleotide-binding oligomerization domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
nucleotide-binding oligomerization domain-containing protein 1 isoform X3
nucleotide-binding oligomerization domain-containing protein 1 isoform X2
nucleotide-binding oligomerization domain-containing protein 1 isoform X1
tigger transposable element-derived protein 1-like
NFX1-type zinc finger-containing protein 1-like, transcript variant X4
NFX1-type zinc finger-containing protein 1-like, transcript variant X3
NFX1-type zinc finger-containing protein 1-like, transcript variant X1
NFX1-type zinc finger-containing protein 1-like, transcript variant X2
NFX1-type zinc finger-containing protein 1-like isoform X3
NFX1-type zinc finger-containing protein 1-like isoform X2
NFX1-type zinc finger-containing protein 1-like isoform X1
small nuclear ribonucleoprotein-associated protein B'-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
small nuclear ribonucleoprotein-associated protein B'-like, transcript variant X2
small nuclear ribonucleoprotein-associated protein B'-like isoform X1
small nuclear ribonucleoprotein-associated protein B'-like isoform X2
aryl hydrocarbon receptor repressor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
aryl hydrocarbon receptor repressor-like, transcript variant X3
aryl hydrocarbon receptor repressor-like, transcript variant X2
aryl hydrocarbon receptor repressor-like isoform X1
aryl hydrocarbon receptor repressor-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
aryl hydrocarbon receptor repressor-like isoform X2
aryl hydrocarbon receptor repressor-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
aryl hydrocarbon receptor repressor-like, transcript variant X7
aryl hydrocarbon receptor repressor-like, transcript variant X5
aryl hydrocarbon receptor repressor-like, transcript variant X9
aryl hydrocarbon receptor-like isoform X3
aryl hydrocarbon receptor repressor-like, transcript variant X8
aryl hydrocarbon receptor-like isoform X4
phosphatidylinositol glycan anchor biosynthesis, class M
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
programmed cell death 6, transcript variant X1
programmed cell death 6, transcript variant X2
programmed cell death 6, transcript variant X3
programmed cell death protein 6 isoform X1
programmed cell death protein 6 isoform X2
programmed cell death protein 6 isoform X3
ankyrin repeat and SAM domain-containing protein 6-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ankyrin repeat and SAM domain-containing protein 6-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
ankyrin repeat and SAM domain-containing protein 6-like isoform X5
ankyrin repeat and SAM domain-containing protein 6-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ankyrin repeat and SAM domain-containing protein 6-like, transcript variant X5
ankyrin repeat and SAM domain-containing protein 6-like isoform X3
ankyrin repeat and SAM domain-containing protein 6-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
ankyrin repeat and SAM domain-containing protein 6-like isoform X4
ankyrin repeat and SAM domain-containing protein 6-like, transcript variant X2
ankyrin repeat and SAM domain-containing protein 6-like, transcript variant X1
ankyrin repeat and SAM domain-containing protein 6-like isoform X2
ankyrin repeat and SAM domain-containing protein 6-like isoform X1
ankyrin repeat and SAM domain-containing protein 6-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ankyrin repeat and SAM domain-containing protein 6-like isoform X6
ankyrin repeat and SAM domain-containing protein 6-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ankyrin repeat and SAM domain-containing protein 6-like isoform X7
ankyrin repeat and SAM domain-containing protein 6-like, transcript variant X10
solute carrier family 12 member 7b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
solute carrier family 12 member 7b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
solute carrier family 12 member 7 isoform X1
solute carrier family 12 member 7 isoform X3
solute carrier family 12 member 7b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
solute carrier family 12 member 7 isoform X2
solute carrier family 12 member 7b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
solute carrier family 12 member 7 isoform X4
solute carrier family 12 member 7b, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
solute carrier family 12 member 7 isoform X5
NKD inhibitor of WNT signaling pathway 2b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
NKD inhibitor of WNT signaling pathway 2b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
NKD inhibitor of WNT signaling pathway 2b, transcript variant X3
protein naked cuticle homolog 2-like isoform X2
protein naked cuticle homolog 2-like isoform X1
protein naked cuticle homolog 2-like isoform X3
thyroid hormone receptor interactor 13, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
thyroid hormone receptor interactor 13, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
thyroid hormone receptor interactor 13, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
thyroid hormone receptor interactor 13, transcript variant X1
thyroid hormone receptor interactor 13, transcript variant X5
pachytene checkpoint protein 2 homolog isoform X1
pachytene checkpoint protein 2 homolog isoform X2
pachytene checkpoint protein 2 homolog isoform X3
thyroid hormone receptor interactor 13, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
pachytene checkpoint protein 2 homolog isoform X4
bromodomain containing 9, transcript variant X3
bromodomain containing 9, transcript variant X4
bromodomain containing 9, transcript variant X1
bromodomain containing 9, transcript variant X2
bromodomain containing 9, transcript variant X5
bromodomain-containing protein 9 isoform X3
bromodomain-containing protein 9 isoform X4
bromodomain-containing protein 9 isoform X1
bromodomain-containing protein 9 isoform X2
bromodomain-containing protein 9 isoform X5
zinc finger DHHC-type containing 11, transcript variant X3
zinc finger DHHC-type containing 11, transcript variant X1
zinc finger DHHC-type containing 11, transcript variant X2
zinc finger DHHC-type containing 11, transcript variant X4
tubulin polymerization-promoting protein, transcript variant X1
tubulin polymerization-promoting protein, transcript variant X2
tubulin polymerization-promoting protein isoform X1
tubulin polymerization-promoting protein isoform X2
tubulin polymerization-promoting protein, transcript variant X3
tubulin polymerization-promoting protein isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
sodium/hydrogen exchanger 3, transcript variant X2
sodium/hydrogen exchanger 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC100009641 homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized protein LOC100009641 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized protein LOC100009641 homolog, transcript variant X1
uncharacterized protein LOC100009641 homolog, transcript variant X2
uncharacterized protein LOC100009641 homolog, transcript variant X4
pleckstrin homology domain-containing family G member 4B isoform X5
pleckstrin homology domain-containing family G member 4B isoform X4
pleckstrin homology domain-containing family G member 4B isoform X1
pleckstrin homology domain-containing family G member 4B isoform X3
pleckstrin homology domain-containing family G member 4B isoform X2
leucine-rich repeat-containing protein 14B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
V-set and transmembrane domain containing 2A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
V-set and transmembrane domain containing 2A, transcript variant X1
V-set and transmembrane domain-containing protein 2A isoform X1
V-set and transmembrane domain-containing protein 2A isoform X2
uncharacterized LOC122564458, transcript variant X3
uncharacterized LOC122564458, transcript variant X2
uncharacterized LOC122564458, transcript variant X1
FH1/FH2 domain-containing protein 3-like, transcript variant X1
FH1/FH2 domain-containing protein 3-like, transcript variant X4
FH1/FH2 domain-containing protein 3-like, transcript variant X5
FH1/FH2 domain-containing protein 3-like, transcript variant X8
FH1/FH2 domain-containing protein 3-like, transcript variant X3
FH1/FH2 domain-containing protein 3-like, transcript variant X9
FH1/FH2 domain-containing protein 3-like, transcript variant X6
FH1/FH2 domain-containing protein 3-like, transcript variant X10
FH1/FH2 domain-containing protein 3-like, transcript variant X13
FH1/FH2 domain-containing protein 3-like, transcript variant X7
FH1/FH2 domain-containing protein 3-like, transcript variant X11
FH1/FH2 domain-containing protein 3-like, transcript variant X12
FH1/FH2 domain-containing protein 3-like, transcript variant X16
FH1/FH2 domain-containing protein 3-like, transcript variant X14
FH1/FH2 domain-containing protein 3-like, transcript variant X17
FH1/FH2 domain-containing protein 3-like, transcript variant X15
FH1/FH2 domain-containing protein 3-like, transcript variant X2
FH1/FH2 domain-containing protein 3-like isoform X1
FH1/FH2 domain-containing protein 3-like isoform X3
FH1/FH2 domain-containing protein 3-like isoform X4
FH1/FH2 domain-containing protein 3-like isoform X7
FH1/FH2 domain-containing protein 3-like isoform X2
FH1/FH2 domain-containing protein 3-like isoform X8
FH1/FH2 domain-containing protein 3-like isoform X5
FH1/FH2 domain-containing protein 3-like isoform X9
FH1/FH2 domain-containing protein 3-like isoform X12
FH1/FH2 domain-containing protein 3-like isoform X6
FH1/FH2 domain-containing protein 3-like isoform X10
FH1/FH2 domain-containing protein 3-like isoform X11
FH1/FH2 domain-containing protein 3-like isoform X15
FH1/FH2 domain-containing protein 3-like isoform X13
FH1/FH2 domain-containing protein 3-like isoform X16
FH1/FH2 domain-containing protein 3-like isoform X14
interferon regulatory factor 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
interferon regulatory factor 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
interferon regulatory factor 4-like isoform X1
interferon regulatory factor 4-like isoform X2
interferon regulatory factor 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
interferon regulatory factor 4-like isoform X3
exocyst complex component 2, transcript variant X3
exocyst complex component 2, transcript variant X2
exocyst complex component 2, transcript variant X1
exocyst complex component 2, transcript variant X4
exocyst complex component 2, transcript variant X6
exocyst complex component 2, transcript variant X5
exocyst complex component 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122564463, transcript variant X2
uncharacterized LOC122564463, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122564468, transcript variant X3
uncharacterized LOC122564468, transcript variant X1
uncharacterized LOC122564468, transcript variant X2
myosin light chain kinase family, member 4b, transcript variant X5
myosin light chain kinase family, member 4b, transcript variant X6
myosin light chain kinase family, member 4b, transcript variant X1
myosin light chain kinase family, member 4b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
myosin light chain kinase family, member 4b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
myosin light chain kinase family, member 4b, transcript variant X2
WRN helicase interacting protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
WRN helicase interacting protein 1, transcript variant X2
WRN helicase interacting protein 1, transcript variant X1
leukocyte elastase inhibitor A-like, transcript variant X1
leukocyte elastase inhibitor A-like, transcript variant X2
leukocyte elastase inhibitor A-like, transcript variant X3
leukocyte elastase inhibitor A-like isoform X1
leukocyte elastase inhibitor A-like isoform X2
leukocyte elastase inhibitor-like, transcript variant X1
leukocyte elastase inhibitor-like, transcript variant X2
leukocyte elastase inhibitor-like isoform X1
leukocyte elastase inhibitor-like isoform X2
uncharacterized protein LOC100150331 homolog, transcript variant X4
uncharacterized protein LOC100150331 homolog, transcript variant X1
uncharacterized protein LOC100150331 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized protein LOC100150331 homolog, transcript variant X2
MARVEL domain-containing protein 3 isoform X2
MARVEL domain-containing protein 3 isoform X3
MARVEL domain-containing protein 3 isoform X1
cleft lip and palate transmembrane protein 1-like protein isoform X1
cleft lip and palate transmembrane protein 1-like protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
inactive sodium-dependent neutral amino acid transporter B(0)AT3-like, transcript variant X1
inactive sodium-dependent neutral amino acid transporter B(0)AT3-like, transcript variant X4
sodium-dependent neutral amino acid transporter B(0)AT3-like isoform X1
sodium-dependent neutral amino acid transporter B(0)AT3-like isoform X3
inactive sodium-dependent neutral amino acid transporter B(0)AT3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
inactive sodium-dependent neutral amino acid transporter B(0)AT3-like, transcript variant X3
sodium-dependent neutral amino acid transporter B(0)AT3-like isoform X2
inactive sodium-dependent neutral amino acid transporter B(0)AT3-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
inactive sodium-dependent neutral amino acid transporter B(0)AT3-like isoform X4
sodium-dependent neutral amino acid transporter B(0)AT1-like
regulation of nuclear pre-mRNA domain-containing protein 1B-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
regulation of nuclear pre-mRNA domain-containing protein 1B-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
regulation of nuclear pre-mRNA domain-containing protein 1B-like isoform X4
regulation of nuclear pre-mRNA domain-containing protein 1B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
regulation of nuclear pre-mRNA domain-containing protein 1A-like isoform X2
regulation of nuclear pre-mRNA domain-containing protein 1B-like, transcript variant X3
regulation of nuclear pre-mRNA domain-containing protein 1A-like isoform X3
regulation of nuclear pre-mRNA domain-containing protein 1B-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
regulation of nuclear pre-mRNA domain-containing protein 1B-like, transcript variant X6
regulation of nuclear pre-mRNA domain-containing protein 1A-like isoform X7
regulation of nuclear pre-mRNA domain-containing protein 1A-like isoform X5
regulation of nuclear pre-mRNA domain-containing protein 1B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
regulation of nuclear pre-mRNA domain-containing protein 1A-like isoform X1
regulation of nuclear pre-mRNA domain-containing protein 1B-like, transcript variant X7
regulation of nuclear pre-mRNA domain-containing protein 1A-like isoform X6
uncharacterized LOC122564300, transcript variant X2
uncharacterized LOC122564300, transcript variant X1
galactosidase, beta 1, transcript variant X1
galactosidase, beta 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 176 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 170 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
C-C chemokine receptor type 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
C-C chemokine receptor type 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
C-C chemokine receptor type 3-like, transcript variant X3
C-C chemokine receptor type 3-like, transcript variant X4
FYVE and coiled-coil domain autophagy adaptor 1a, transcript variant X2
FYVE and coiled-coil domain autophagy adaptor 1a, transcript variant X4
FYVE and coiled-coil domain autophagy adaptor 1a, transcript variant X1
FYVE and coiled-coil domain autophagy adaptor 1a, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
FYVE and coiled-coil domain autophagy adaptor 1a, transcript variant X3
FYVE and coiled-coil domain-containing protein 1 isoform X1
FYVE and coiled-coil domain-containing protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
leucine zipper transcription factor-like 1, transcript variant X2
leucine zipper transcription factor-like protein 1 isoform X2
leucine zipper transcription factor-like 1, transcript variant X3
leucine zipper transcription factor-like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
leucine zipper transcription factor-like protein 1 isoform X3
leucine zipper transcription factor-like protein 1 isoform X1
carnitine deficiency-associated gene expressed in ventricle 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
carnitine deficiency-associated gene expressed in ventricle 3, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
DNA topoisomerase II binding protein 1, transcript variant X2
DNA topoisomerase II binding protein 1, transcript variant X1
dnaJ homolog subfamily C member 13, transcript variant X5
dnaJ homolog subfamily C member 13, transcript variant X3
dnaJ homolog subfamily C member 13, transcript variant X4
dnaJ homolog subfamily C member 13, transcript variant X2
dnaJ homolog subfamily C member 13, transcript variant X1
dnaJ homolog subfamily C member 13 isoform X2
dnaJ homolog subfamily C member 13 isoform X1
dnaJ homolog subfamily C member 13 isoform X3
dnaJ homolog subfamily C member 13, transcript variant X6
dnaJ homolog subfamily C member 13 isoform X4
receptor (TNFRSF)-interacting serine-threonine kinase 1, like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
receptor (TNFRSF)-interacting serine-threonine kinase 1, like, transcript variant X2
receptor (TNFRSF)-interacting serine-threonine kinase 1, like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
receptor-interacting serine/threonine-protein kinase 1 isoform X1
receptor (TNFRSF)-interacting serine-threonine kinase 1, like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
receptor-interacting serine/threonine-protein kinase 1 isoform X2
receptor (TNFRSF)-interacting serine-threonine kinase 1, like, transcript variant X5
receptor-interacting serine/threonine-protein kinase 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tubulin beta chain, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 292 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tubulin beta chain, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
proteasome (prosome, macropain) assembly chaperone 4, transcript variant X2
proteasome (prosome, macropain) assembly chaperone 4, transcript variant X3
proteasome (prosome, macropain) assembly chaperone 4, transcript variant X1
proteasome assembly chaperone 4 isoform X1
proteasome assembly chaperone 4 isoform X3
proteasome assembly chaperone 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
uncharacterized LOC122564504, transcript variant X2
uncharacterized LOC122564504, transcript variant X1
uncharacterized LOC122564504, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 72% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein C6orf201 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 81% coverage of the annotated genomic feature by RNAseq alignments
enoyl-CoA delta isomerase 2, transcript variant X1
enoyl-CoA delta isomerase 2, transcript variant X2
enoyl-CoA delta isomerase 2, transcript variant X3
enoyl-CoA delta isomerase 2, transcript variant X4
enoyl-CoA delta isomerase 2, mitochondrial isoform X1
enoyl-CoA delta isomerase 2, mitochondrial isoform X2
chromodomain protein, Y-like, transcript variant X3
chromodomain protein, Y-like, transcript variant X2
chromodomain protein, Y-like, transcript variant X1
chromodomain protein, Y-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 3G
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
LYR motif-containing protein 4-like, transcript variant X2
LYR motif-containing protein 4-like isoform X2
LYR motif-containing protein 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
LYR motif-containing protein 4-like isoform X1
phenylalanyl-tRNA synthetase 2, mitochondrial, transcript variant X4
phenylalanyl-tRNA synthetase 2, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
phenylalanyl-tRNA synthetase 2, mitochondrial, transcript variant X1
phenylalanyl-tRNA synthetase 2, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
phenylalanyl-tRNA synthetase 2, mitochondrial, transcript variant X7
phenylalanine--tRNA ligase, mitochondrial isoform X4
phenylalanine--tRNA ligase, mitochondrial isoform X2
phenylalanine--tRNA ligase, mitochondrial isoform X1
phenylalanine--tRNA ligase, mitochondrial isoform X3
phenylalanine--tRNA ligase, mitochondrial isoform X6
phenylalanyl-tRNA synthetase 2, mitochondrial, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
phenylalanyl-tRNA synthetase 2, mitochondrial, transcript variant X6
phenylalanine--tRNA ligase, mitochondrial isoform X5
ras responsive element binding protein 1a, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ras responsive element binding protein 1a, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ras responsive element binding protein 1a, transcript variant X1
ras responsive element binding protein 1a, transcript variant X4
ras responsive element binding protein 1a, transcript variant X2
ras-responsive element-binding protein 1 isoform X1
ras-responsive element-binding protein 1 isoform X4
ras-responsive element-binding protein 1 isoform X2
ras-responsive element-binding protein 1 isoform X6
ras responsive element binding protein 1a, transcript variant X8
ras responsive element binding protein 1a, transcript variant X3
ras-responsive element-binding protein 1 isoform X3
ras responsive element binding protein 1a, transcript variant X5
ras-responsive element-binding protein 1 isoform X5
ras responsive element binding protein 1a, transcript variant X9
ras-responsive element-binding protein 1 isoform X7
ras responsive element binding protein 1a, transcript variant X10
ras-responsive element-binding protein 1 isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
signal sequence receptor, alpha, transcript variant X1
signal sequence receptor, alpha, transcript variant X2
translocon-associated protein subunit alpha isoform X2
translocon-associated protein subunit alpha isoform X1
nephronophthisis 3, transcript variant X1
nephronophthisis 3, transcript variant X2
nephronophthisis 3, transcript variant X3
ubiquitin-like modifier activating enzyme 5, transcript variant X1
ubiquitin-like modifier activating enzyme 5, transcript variant X2
ubiquitin-like modifier-activating enzyme 5 isoform X2
ubiquitin-like modifier-activating enzyme 5 isoform X1
acyl-CoA dehydrogenase family member 11-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90% coverage of the annotated genomic feature by RNAseq alignments
acyl-CoA dehydrogenase family, member 11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
rab effector MyRIP-like, transcript variant X3
rab effector MyRIP-like, transcript variant X1
rab effector MyRIP-like, transcript variant X2
rab effector MyRIP-like, transcript variant X4
eukaryotic translation initiation factor 1b
cholecystokinin-like, transcript variant X1
cholecystokinin-like, transcript variant X2
trafficking protein, kinesin binding 1a, transcript variant X3
trafficking protein, kinesin binding 1a, transcript variant X2
trafficking protein, kinesin binding 1a, transcript variant X1
trafficking protein, kinesin binding 1a, transcript variant X4
trafficking protein, kinesin binding 1a, transcript variant X5
trafficking protein, kinesin binding 1a, transcript variant X7
trafficking protein, kinesin binding 1a, transcript variant X8
trafficking protein, kinesin binding 1a, transcript variant X6
trafficking kinesin-binding protein 1 isoform X3
trafficking kinesin-binding protein 1 isoform X1
trafficking kinesin-binding protein 1 isoform X2
trafficking kinesin-binding protein 1 isoform X4
trafficking kinesin-binding protein 1 isoform X7
trafficking kinesin-binding protein 1 isoform X6
trafficking kinesin-binding protein 1 isoform X5
unc-51 like kinase 4, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
unc-51 like kinase 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
unc-51 like kinase 4, transcript variant X2
unc-51 like kinase 4, transcript variant X1
unc-51 like kinase 4, transcript variant X13
unc-51 like kinase 4, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
unc-51 like kinase 4, transcript variant X11
unc-51 like kinase 4, transcript variant X12
unc-51 like kinase 4, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
unc-51 like kinase 4, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
unc-51 like kinase 4, transcript variant X19
unc-51 like kinase 4, transcript variant X16
unc-51 like kinase 4, transcript variant X15
unc-51 like kinase 4, transcript variant X20
unc-51 like kinase 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
unc-51 like kinase 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
unc-51 like kinase 4, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
unc-51 like kinase 4, transcript variant X7
unc-51 like kinase 4, transcript variant X8
unc-51 like kinase 4, transcript variant X5
serine/threonine-protein kinase ULK4 isoform X1
serine/threonine-protein kinase ULK4 isoform X4
serine/threonine-protein kinase ULK4 isoform X5
serine/threonine-protein kinase ULK4 isoform X2
serine/threonine-protein kinase ULK4 isoform X6
serine/threonine-protein kinase ULK4 isoform X3
serine/threonine-protein kinase ULK4 isoform X8
serine/threonine-protein kinase ULK4 isoform X9
serine/threonine-protein kinase ULK4 isoform X7
unc-51 like kinase 4, transcript variant X21
serine/threonine-protein kinase ULK4 isoform X10
catenin (cadherin-associated protein), beta 1, transcript variant X2
catenin (cadherin-associated protein), beta 1, transcript variant X1
uncharacterized protein KIAA1143 homolog
kinesin family member 15, transcript variant X1
kinesin family member 15, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transmembrane protein 42a, transcript variant X2
transmembrane protein 42a, transcript variant X1
palmitoyltransferase ZDHHC3, transcript variant X3
palmitoyltransferase ZDHHC3, transcript variant X1
palmitoyltransferase ZDHHC3, transcript variant X2
palmitoyltransferase ZDHHC3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
palmitoyltransferase ZDHHC3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
palmitoyltransferase ZDHHC3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins
leucyl-tRNA synthetase 2, mitochondrial, transcript variant X4
leucyl-tRNA synthetase 2, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucyl-tRNA synthetase 2, mitochondrial, transcript variant X5
leucyl-tRNA synthetase 2, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
leucyl-tRNA synthetase 2, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
probable leucine--tRNA ligase, mitochondrial isoform X1
probable leucine--tRNA ligase, mitochondrial isoform X3
probable leucine--tRNA ligase, mitochondrial isoform X2
LIM domain-containing protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
LIM domain-containing protein 1-like isoform X1
LIM domain-containing protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
LIM domain-containing protein 1-like isoform X2
phosphatidylinositol-3-phosphatase SAC1-like, transcript variant X1
phosphatidylinositol-3-phosphatase SAC1-like, transcript variant X2
phosphatidylinositol-3-phosphatase SAC1-like isoform X1
phosphatidylinositol-3-phosphatase SAC1-like isoform X2
small nuclear ribonucleoprotein D1 polypeptide
sodium- and chloride-dependent transporter XTRP3A-like, transcript variant X1
sodium- and chloride-dependent transporter XTRP3A-like, transcript variant X2
sodium- and chloride-dependent transporter XTRP3A-like isoform X1
sodium- and chloride-dependent transporter XTRP3A-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
NIMA-related kinase 11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
NIMA-related kinase 11, transcript variant X1
NIMA-related kinase 11, transcript variant X4
NIMA-related kinase 11, transcript variant X3
serine/threonine-protein kinase Nek11 isoform X1
serine/threonine-protein kinase Nek11 isoform X2
HscB mitochondrial iron-sulfur cluster cochaperone
iron-sulfur cluster co-chaperone protein HscB
protein asteroid homolog 1-like, transcript variant X1
protein asteroid homolog 1-like isoform X1
protein asteroid homolog 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
protein asteroid homolog 1-like isoform X2
ATPase secretory pathway Ca2+ transporting 1, transcript variant X1
calcium-transporting ATPase type 2C member 1 isoform X1
ATPase secretory pathway Ca2+ transporting 1, transcript variant X2
calcium-transporting ATPase type 2C member 1 isoform X2
PH domain leucine-rich repeat protein phosphatase 1-like
zinc finger CCHC domain-containing protein 2-like
RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing, transcript variant X4
RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing, transcript variant X2
RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing, transcript variant X1
RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing, transcript variant X5
RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing, transcript variant X3
RAB11-binding protein RELCH homolog isoform X5
RAB11-binding protein RELCH homolog isoform X4
RAB11-binding protein RELCH homolog isoform X3
RAB11-binding protein RELCH homolog isoform X2
RAB11-binding protein RELCH homolog isoform X1
phosphatidylinositol glycan anchor biosynthesis, class N, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
GPI ethanolamine phosphate transferase 1 isoform X1
phosphatidylinositol glycan anchor biosynthesis, class N, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
phosphatidylinositol glycan anchor biosynthesis, class N, transcript variant X3
GPI ethanolamine phosphate transferase 1 isoform X2
GPI ethanolamine phosphate transferase 1 isoform X3
ring finger protein 152, transcript variant X1
ring finger protein 152, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate decarboxylase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate decarboxylase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glutamate decarboxylase 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 131 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
chromosome 29 C5orf22 homolog, transcript variant X1
chromosome 29 C5orf22 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
UPF0489 protein C5orf22 homolog isoform X1
UPF0489 protein C5orf22 homolog isoform X3
chromosome 29 C5orf22 homolog, transcript variant X2
UPF0489 protein C5orf22 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cadherin-12-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122564309, transcript variant X2
uncharacterized LOC122564309, transcript variant X1
brain acid soluble protein 1-like, transcript variant X3
brain acid soluble protein 1-like, transcript variant X1
brain acid soluble protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
importin subunit alpha-7, transcript variant X2
importin subunit alpha-7, transcript variant X1
coiled-coil domain containing 28B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
coiled-coil domain containing 28B, transcript variant X1
coiled-coil domain-containing protein 28B
histone-binding protein RBBP4, transcript variant X5
histone-binding protein RBBP4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
histone-binding protein RBBP4, transcript variant X6
histone-binding protein RBBP4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
histone-binding protein RBBP4, transcript variant X1
histone-binding protein RBBP4, transcript variant X4
histone-binding protein RBBP4 isoform X1
histone-binding protein RBBP4 isoform X2
histone-binding protein RBBP4 isoform X4
histone-binding protein RBBP4 isoform X3
histone-binding protein RBBP4 isoform X5
histone-binding protein RBBP4, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
histone-binding protein RBBP4 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC122564571 isoform X2
uncharacterized protein KIAA1522 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein KIAA1522 homolog isoform X1
uncharacterized protein KIAA1522 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized protein KIAA1522 homolog isoform X2
uncharacterized protein KIAA1522 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein KIAA1522 homolog isoform X3
tumor necrosis factor alpha-induced protein 3-like
testis-specific serine/threonine-protein kinase 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments